75 Biggest Movers From Yesterday

Gainers

• Aurinia Pharmaceuticals Inc. AUPH shares jumped 78.8% to close at $15.00 on Thursday after the company reported positive clinical readout for its lead asset voclosporin in treating lupus nephritis, an autoimmune disorder. Aurinia has a single-product pipeline. Voclosporin is being evaluated for multiple indications. The investigational asset is in the most advanced stage of clinical development for lupus nephritis. The company announced positive safety and efficacy data from its pivotal Phase 3 study of voclosporin, in combination with mycophenolate, the current standard of care, and low-dose corticosteroids in the treatment of lupus nephritis.
• Proteostasis Therapeutics, Inc. PTI gained 35.4% to close at $3.79.
• Secureworks Corp SCWX climbed 29.5% to close at $14.55 after the company reported better-than-expected Q3 EPS and sales results. The company reported Q4 and FY20 EPS and sales guidance above analyst estimates.
• Iterum Therapeutics plc ITRM rose 29.1% to close at $3.55.
• Express, Inc. EXPR shares gained 27.9% to close at $5.00 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 EPS guidance above analyst estimates.
• Duluth Holdings Inc. DLTH rose 24.6% to close at $9.73 after the company reported better-than-expected Q3 results.
• DermTech, Inc. DMTK gained 24.2% to close at $9.44.
• Syndax Pharmaceuticals, Inc. SNDX surged 21.5% to close at $8.81.
• Bicycle Therapeutics plc BCYC gained 17.7% to close at $9.00.
• Tilly's Inc TLYS rose 16.8% to close at $11.70 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and sales guidance above analyst estimates.
• Synthorx, Inc. THOR surged 16.5% to close at $24.98.
• Hovnanian Enterprises, Inc. HOV gained 16.4% to close at $24.96 following Q4 results.
• AZZ Inc. AZZ gained 14.9% to close at $44.04 after reporting upbeat Q2 results.
• Powell Industries, Inc. POWL gained 14.8% to close at $45.43 following better-than-expected Q4 results.
• Patterson Companies, Inc. PDCO shares rose 14.2% to close at $23.10 after the company posted upbeat Q2 earnings and raised FY20 EPS guidance.
• ACADIA Pharmaceuticals Inc. ACAD jumped 14% to close at $50.48 after the company reported the results from its pivotal phase 3 HARMONY trial of pimavanserin in patients with dementia-related psychosis met the primary endpoint and key secondary endpoint.
• Restoration Hardware Holdings, Inc RH gained 13.4% to close at $233.17 after the company reported better-than-expected Q3 EPS and sales results.
• Mitcham Industries, Inc. MIND gained 12.4% to close at $2.36 following strong Q3 results.
• Lexicon Pharmaceuticals, Inc. LXRX climbed 12.2% to close at $4.23 after the company reported the topline Phase 1 data for its LX9211. NOTE: The study showed favorable safety results.
• Stage Stores, Inc. SSI gained 12.1% to close at $5.48.
• Enel Chile S.A. ENIC rose 11.9% to close at $4.32.
• Atreca, Inc. BCEL gained 11.7% to close at $14.47.
• Precision BioSciences, Inc. DTIL surged 11.2% to close at $18.51.
• Corvus Pharmaceuticals, Inc. CRVS jumped 10.7% to close at $4.56.
• Rubius Therapeutics, Inc. RUBY gained 10.6% to close at $10.34.
• ChemoCentryx, Inc. CCXI climbed 10.6% to close at $31.05.
• SeaChange International, Inc. SEAC gained 10.5% to close at $4.00.
• StoneMor Partners L.P. STON rose 10.4% to close at $1.17 after the company announced an agreement to sell Oakmont Memorial Park & Mortuary to Carriage Services for $33 million.
• Artelo Biosciences, Inc. ARTL climbed 10.3% to close at $2.58.
• SMTC Corporation SMTX gained 9.9% to close at $3.34.
• Sportsman's Warehouse Holdings Inc SPWH rose 9.8% to close at $8.05 after the company reported better-than-expected Q3 sales results. The company also issued FY19 EPS guidance above analyst estimates.
• Akero Therapeutics, Inc. AKRO gained 9.7% to close at $22.06.
• Baudax Bio, Inc. BXRX rose 9.5% to close at $6.33.
• WideOpenWest, Inc. WOW climbed 7.5% to close at $6.74.
• Signet Jewelers Limited SIG rose 7.5% to close at $17.89 following upbeat Q3 results.
• Verint Systems Inc. VRNT gained 6.9% to close at $51.09 after the company reported upbeat Q3 earnings and announced plans to separate into 2 publicly-traded companies.
• Predictive Oncology Inc. POAI climbed 6.4% to close at $3.00 after the company confirmed indications of interest for Skyline Medical business.
• SunCoke Energy Inc SXC gained 5.7% to close at $5.41 after B.Riley upgraded the stock from Neutral to Buy and announced a price target of $8 per share.
• Five Below Inc FIVE shares rose 4.8% to close at $123.67. Five Below reported in-line Q3 earnings, while sales exceeded estimates. The company also raised the low end of FY19 earnings guidance.
• Synthesis Energy Systems, Inc. SES gained 4.2% to close at $6.21 after the company announced it has completed the Batchfire pre-emptive rights process. The company will increase its ownership in Batchfire from 7.4% to 37.2%.

Check out these big penny stock gainers and losers

Losers

• Sage Therapeutics, Inc. SAGE shares tumbled 59.7% to close at $60.18 on Thursday following news topline results from a Phase 3 study of SAGE-217 did not meet a primary endpoint at day 15 of the trial.
• Akers Biosciences, Inc. AKER shares fell 42.6% to close at $3.16. Akers Biosciences priced its 1.99 million unit offering at $4 per unit. The company disclosed that it will continue its strategic review and explore entering the hemp and minor cannabinoid processing industry.
• At Home Group Inc. HOME tumbled 35.9% to close at $5.48 after the company issued Q4 and FY20 EPS and sales guidance below analyst estimates.
• Kirkland's, Inc. KIRK fell 31.4% to close at $0.9120 following Q3 results.
• Cancer Genetics, Inc. CGIX dipped 28.4% to close at $5.51.
• J.Jill Inc JILL fell 27.9% to close at $1.24 after the company reported downbeat Q3 results and lowered FY19 guidance. The company also disclosed that President and CEO Linda Heasley is stepping down.
• Clovis Oncology Inc CLVS dropped 26.9% to close at $8.86.
• BioLineRx Ltd. BLRX fell 26.1% to close at $2.04 after the company reported preliminary Phase 2a data from triple combo arm of COMBAT/KEYNOTE-202 study in second-line patients with metastatic pancreatic cancer.
• Millendo Therapeutics, Inc. MLND shares fell 22.7% to close at $6.00. Millendo Therapeutics priced its 4.1 million share public offering of common stock at $6.00 per share.
• KLX Energy Services Holdings, Inc. KLXE dipped 19.9% to close at $4.23 after reporting Q3 results.
• Elastic N.V. ESTC fell 17.9% to close at $64.22 despite the company reporting better-than-expected Q2 EPS and sales results.
• Puma Biotechnology, Inc. PBYI dropped 16.9% to close at $7.44.
• Centogene N.V. CNTG dipped 16.5% to close at $10.65 after the company reported financial results for the third quarter and the nine months ended September 30, 2019.
• Michaels Companies Inc MIK fell 15.7% to close at $6.08 after the company reported downbeat Q3 results and issued weak Q4 forecast.
• Allena Pharmaceuticals, Inc. ALNA fell 15.6% to close at $1.95. Allena Pharmaceuticals announced a clinical and corporate update, wherein it said it would undertake several initiatives to realign resources to support the continued development of its orally administered enzyme for the treatment of patients with enteric hyperoxaluria.
• Altimmune, Inc. ALT fell 14.5% to close at $1.83.
• Apellis Pharmaceuticals, Inc. APLS dropped 13.6% to close at $25.85.
• VolitionRx Limited VNRX dipped 13.4% to close at $4.28. VolitionRx and Gyros Protein Technologies were awarded an aggregate $1 million+ Eurostars cash grant to collaborate on developing a lung cancer blood test.
• Mallinckrodt plc MNK dropped 12.9% to close at $3.38.
• PolarityTE, Inc. PTE tumbled 12.8% to close at $2.59. PolarityTE reported an equity purchase deal with Keystone Capital for up to $25 million.
• Omeros Corporation OMER fell 12.7% to close at $13.31 after the company reported a proposed public offering of common stock priced in the $13.10-$13.40 per share range.
• Pieris Pharmaceuticals, Inc. PIRS dropped 12.7% to close at $3.43.
• Endo International plc ENDP shares declined 12.4% to close at $4.82.
• Kodiak Sciences Inc. KOD fell 12.3% to close at $64.41 after rising 49.21% on Wednesday.
• Kaleido BioSciences, Inc. KLDO dropped 12.1% to close at $6.42.
• Relmada Therapeutics, Inc. RLMD fell 11% to close at $42.00 after surging 36.91% on Wednesday.
• ESSA Pharma Inc. EPIX fell 10.9% to close at $4.99.
• Allakos Inc. ALLK dropped 10.7% to close at $123.06 as a potential sell-off after the stock increased roughly 40% Wednesday following reports stating the company is weighing a potential sale.
• ReWalk Robotics Ltd. RWLK dipped 10.6% to close at $2.52.
• Applied Therapeutics, Inc. APLT fell 10.4% to close at $21.50.
• Sorrento Therapeutics, Inc. SRNE fell 10.4% to close at $3.26as a potential sell-off after the stock increased roughly 135% since November 22.
• Cue Biopharma, Inc. CUE dropped 10% to close at $11.33.
• Majesco MJCO fell 9.7% to close at $7.40.
• Can-Fite BioPharma Ltd. CANF shares declined 9.3% to close at $3.99.
• GrafTech International Ltd EAF dropped 9.3% to close at $12.63 after the company announced a majority stockholder has launched a Rule 144 secondary block trade to sell 11.18 million shares of the company's stock to Morgan Stanley.